Publication | Open Access
Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells
35
Citations
54
References
2022
Year
These results suggest that targeting the tumor-specific fibronectin splice variant EDA with CAR-T cells is feasible and offers a therapeutic option that is applicable to different types of cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1